Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 31NIH 17NETWORK 14INDUSTRY 7OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 5Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Pathologic Complete Response 2Fallopian Tube Neoplasms 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thymoma 1Testicular Neoplasms 1Recurrence 1Ovarian Neoplasms 1Non-squamous Cell Non-Small Cell Lung Cancer 1Non-Squamous Non-Small Cell Lung Cancer 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1HER2 Positive Breast Cancer 1Endometrial Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1Carcinoma, Ovarian Epithelial 1

Interventions

Pemetrexed 3Gefitinib 2Carboplatin 2icotinib 1endostar protein 1apatinib 1Platinum Compounds 1Endostatins 1Drug Therapy 1Cisplatin 1Bevacizumab 1Berberine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Adenocarcinoma of Lung × Carboplatin × Clear all
NCT02737774 2020-07-01

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

Henan Cancer Hospital

Phase 2 Unknown
60 enrolled
Thoracic

Adenocarcinoma of Lung

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Anhui Provincial Hospital

Phase 4 Unknown
100 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡